TITLE:
Mediastinal Liposarcoma: Case Report and Literature Review
AUTHORS:
Jeronimo Garcialopez De Llano, Maria Fernanda Mijares, Vanitha Vasudevan, Rodrigo Arrangoiz, Amit Sastry, Frank De la Cruz, Jennifer Fernandez Garcia, Adrian Legaspi
KEYWORDS:
Liposarcoma (LS), Well-Differentiated Liposarcoma (WDLS), Dedifferentiated Liposarcoma (DDLS)
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.12 No.4,
April
29,
2021
ABSTRACT: Liposarcomas
(LS) are the second most common type of soft tissue malignancies in adults; they
arise from mesenchymal cells and account for 1% of all adult cancers and 15% of
all pediatric cancers. The site of origin can be from anywhere there is fat in the
human body. LS are classified based on the primary site of origin, and mediastinal
LS are extremely rare. When mediastinal neoplasms are stratified based on histology,
they represent less than 1% of all mediastinal
tumors. To date, less than 150 cases have been reported in the English literature.
This article aims to present an unusual case of an extremely rare malignancy and
perform a systematic review of the latest literature. In this report, our group is documenting the presentation,
management, and outcome of a 65-year-old male patient with a massive anterior
mediastinal primary LS. The tumor was displacing the mediastinum into the right
chest, occupying most of the left chest, and pushing the diaphragm into the abdomen.
Mediastinal liposarcomas are extremely rare malignancies and can prove to be challenging
to diagnose and treat. Aggressive surgical treatment with R0 resection is the gold
standard, however, tumor biology in many cases is associated with variable growth
rates and encroachment of adjacent vital structures and blood vessels. When complex
anatomical structures preclude an R0 resection, there is a high incidence of local
recurrence. In cases where there is a high risk of recurrence, radiotherapy is indicated
and chemotherapy has a more limited role.